What is the current annual EBITDA of STE?

As of today, STE annual EBITDA is $1.63B

What is 1-year change in STE annual EBITDA?

STE annual EBITDA is up +11.68% year-over-year

What is 3-year change in STE annual EBITDA?

STE annual EBITDA is up +19.76% over the past 3 years

How far is STE annual EBITDA from its all-time high?

STE annual EBITDA is currently at its all-time high

How does STE annual EBITDA rank versus sector peers?

STE annual EBITDA is higher than 94.93% of companies in Healthcare sector

When is STE next annual earnings release?

As of today, the next annual earnings release for STE has not been scheduled

What is the current quarterly EBITDA of STE?

As of today, STE quarterly EBITDA is $477.30M

What is STE quarterly EBITDA most recent change?

STE quarterly EBITDA was up +19.65% on March 31, 2026

What is 1-year change in STE quarterly EBITDA?

STE quarterly EBITDA is up +14.62% year-over-year

How far is STE quarterly EBITDA from its all-time high?

STE quarterly EBITDA is currently at its all-time high

How does STE quarterly EBITDA rank versus sector peers?

STE quarterly EBITDA is higher than 94.72% of companies in Healthcare sector

When is STE next earnings release?

The next earnings release for STE is on November 4, 2026

What is the current TTM EBITDA of STE?

As of today, STE TTM EBITDA is $1.63B

What is STE TTM EBITDA most recent change?

STE TTM EBITDA was up +3.87% on March 31, 2026

What is 1-year change in STE TTM EBITDA?

STE TTM EBITDA is up +9.74% year-over-year

How far is STE TTM EBITDA from its all-time high?

STE TTM EBITDA is currently at its all-time high

How does STE TTM EBITDA rank versus sector peers?

STE TTM EBITDA is higher than 94.72% of companies in Healthcare sector

When is STE next earnings release?

The next earnings release for STE is on November 4, 2026

STERIS Plc (STE) EBITDA History & Chart Since 1990

Annual EBITDA

$1.63B$170.88M+11.68%

March 31, 2026

Summary

Current Value: As of today, STE annual EBITDA is $1.63B, up +11.68% on March 31, 2026
Historical Performance: STE annual EBITDA is up +19.76% over the past 3 years, up +97.49% over the past 5 years
All-Time High Comparison: STE annual EBITDA is currently at its all-time high
3-Year Low Comparison: STE annual EBITDA is +19.76% above its 3-year low of $1.36B reached on an earlier date
Sector Comparison: STE annual EBITDA is higher than 94.93% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

STE Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Mar 31, 26	$1.63B	+11.7%	+19.8%	+97.5%	+1076.9%
Quarterly EBITDA	Mar 31, 26	$477.30M	+14.6%	+26.1%	+117.0%	+558.0%
TTM EBITDA	Mar 31, 26	$1.63B	+9.7%	+22.0%	+100.0%	+1081.0%
Price	Aug 7, 26	$237.47	+0.5%	+5.0%	+9.8%	+669.5%
PE Ratio	Aug 7, 26	29.93	-16.4%	-84.0%	-53.6%	+101.7%
Annual Revenue	Mar 31, 26	$5.94B	+8.7%	+30.9%	+91.0%	+391.6%
Annual EPS	Mar 31, 26	$7.93	+24.9%	+642.3%	+71.3%	+832.5%
	Mar 31, 26	$1.11B	+12.1%	+36.3%	+81.9%	+1210.1%
Annual Net Income	Mar 31, 26	$785.10M	+28.4%	+41.2%	+97.8%	+1431.5%

EBITDA Highs

STE Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$1.63B	Mar 31, 26	at high
5Y	$1.63B	Mar 31, 26	at high
All	$1.63B	Mar 31, 26	at high

EBITDA Lows

STE Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	$1.36B	N/A	+19.8%
5Y	$827.18M	N/A	+97.5%
All	$212.10K	Mar 31, 92	>+9999.0%

EBITDA History

Year	Value	Change
2026	$1.63B	+11.7%
2025	$1.46B	-0.7%
2024	$1.47B	+8.0%
2023	$1.36B	+16.1%
2022	$1.18B	+42.1%
2021	$827.18M	+10.0%
2020	$751.73M	+9.9%
2019	$684.11M	+12.2%
2018	$609.47M	+20.5%
2017	$505.90M	+7.3%
2016	$471.50M	+43.5%
2015	$328.59M	+7.3%
2014	$306.26M	-3.6%
2013	$317.67M	+10.1%
2012	$288.53M	+107.9%
2011	$138.80M	-47.3%
2010	$263.41M	+10.8%
2009	$237.77M	+17.8%

Year	Value	Change
2008	$201.78M	-1.3%
2007	$204.54M	+3.9%
2006	$196.93M	+2.3%
2005	$192.54M	+1.8%
2004	$189.04M	+9.7%
2003	$172.28M	+35.1%
2002	$127.50M	+13.6%
2001	$112.22M	+2.9%
2000	$109.10M	-35.7%
1999	$169.66M	+24.0%
1998	$136.82M	+35.6%
1997	$100.87M	+357.6%
1996	$22.04M	+53.3%
1995	$14.38M	+65.6%
1994	$8.68M	+227.7%
1993	$2.65M	+1,149.0%
1992	$212.10K	-47.0%
1991	$400.00K	-

FAQ

What is the current annual EBITDA of STE?: As of today, STE annual EBITDA is $1.63B
What is 1-year change in STE annual EBITDA?: STE annual EBITDA is up +11.68% year-over-year
What is 3-year change in STE annual EBITDA?: STE annual EBITDA is up +19.76% over the past 3 years
How far is STE annual EBITDA from its all-time high?: STE annual EBITDA is currently at its all-time high
How does STE annual EBITDA rank versus sector peers?: STE annual EBITDA is higher than 94.93% of companies in Healthcare sector
When is STE next annual earnings release?: As of today, the next annual earnings release for STE has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$477.30M$78.40M+19.65%

March 31, 2026

Summary

Current Value: As of today, STE quarterly EBITDA is $477.30M, up +19.65% on March 31, 2026
Historical Performance: STE quarterly EBITDA is up +14.62% year-over-year, up +26.13% over the past 3 years
All-Time High Comparison: STE quarterly EBITDA is currently at its all-time high
3-Year Low Comparison: STE quarterly EBITDA is +42.27% above its 3-year low of $335.48M reached on an earlier date
Sector Comparison: STE quarterly EBITDA is higher than 94.72% of companies in Healthcare sector

Performance

STE Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Mar 31, 26	$477.30M	+19.6%	+14.6%	+26.1%	+117.0%
Annual EBITDA	Mar 31, 26	$1.63B	–	+11.7%	+19.8%	+97.5%
TTM EBITDA	Mar 31, 26	$1.63B	+3.9%	+9.7%	+22.0%	+100.0%
Price	Aug 7, 26	$237.47	+11.1%	+0.5%	+5.0%	+9.8%
PE Ratio	Aug 7, 26	29.93	+11.1%	-16.4%	-84.0%	-53.6%
Quarterly Revenue	Mar 31, 26	$1.59B	+6.2%	+7.3%	+24.0%	+81.8%
Quarterly EPS	Mar 31, 26	$2.24	+14.4%	+46.0%	+19.1%	+116.8%
	Mar 31, 26	$316.50M	+14.3%	+7.6%	+34.0%	+96.8%
Quarterly Net Income	Mar 31, 26	$220.40M	+13.4%	+50.1%	+21.0%	+150.0%

Quarterly EBITDA Highs

STE Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$477.30M	Mar 31, 26	at high
3Y	$477.30M	Mar 31, 26	at high
5Y	$477.30M	Mar 31, 26	at high
All	$477.30M	Mar 31, 26	at high

Quarterly EBITDA Lows

STE Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$366.30M	N/A	+30.3%
3Y	$335.48M	N/A	+42.3%
5Y	$237.23M	N/A	+101.2%
All	-$49.62M	Jun 30, 10	+1061.9%

Quarterly EBITDA History

Month	Value	Change
Mar 2026	$477.30M	+19.7%
Dec 2025	$398.90M	+2.1%
Sep 2025	$390.60M	+6.6%
Jun 2025	$366.30M	-12.0%
Mar 2025	$416.44M	+10.6%
Dec 2024	$376.54M	+10.6%
Sep 2024	$340.55M	-4.0%
Jun 2024	$354.64M	-6.5%
Mar 2024	$379.27M	+1.6%
Dec 2023	$373.41M	+3.8%
Sep 2023	$359.87M	+7.3%
Jun 2023	$335.48M	-11.3%
Mar 2023	$378.42M	+14.4%
Dec 2022	$330.91M	+3.1%
Sep 2022	$320.99M	+4.0%
Jun 2022	$308.54M	-14.0%
Mar 2022	$358.60M	+9.3%
Dec 2021	$328.12M	+30.7%
Sep 2021	$251.13M	+5.9%
Jun 2021	$237.23M	+7.9%
Mar 2021	$219.90M	-0.7%
Dec 2020	$221.40M	+10.3%
Sep 2020	$200.67M	+15.0%
Jun 2020	$174.57M	-17.8%
Mar 2020	$212.47M	+9.1%
Dec 2019	$194.78M	+9.7%
Sep 2019	$177.63M	+8.6%
Jun 2019	$163.56M	-11.8%
Mar 2019	$185.53M	-0.8%
Dec 2018	$187.09M	+20.5%
Sep 2018	$155.27M	+8.9%
Jun 2018	$142.55M	-12.4%
Mar 2018	$162.76M	+14.9%
Dec 2017	$141.68M	-4.3%
Sep 2017	$147.98M	+10.2%
Jun 2017	$134.24M	+43.9%
Mar 2017	$93.32M	-38.9%
Dec 2016	$152.61M	+8.7%
Sep 2016	$140.45M	+5.2%
Jun 2016	$133.50M	-12.3%
Mar 2016	$152.30M	+21.5%
Dec 2015	$125.33M	+78.8%
Sep 2015	$70.11M	-6.7%
Jun 2015	$75.12M	-16.6%
Mar 2015	$90.04M	+9.1%
Dec 2014	$82.54M	+0.1%
Sep 2014	$82.48M	+20.4%
Jun 2014	$68.49M	-32.1%
Mar 2014	$100.81M	+31.6%
Dec 2013	$76.62M	+12.8%
Sep 2013	$67.94M	+12.9%
Jun 2013	$60.19M	-30.1%
Mar 2013	$86.13M	-1.3%
Dec 2012	$87.26M	+12.4%
Sep 2012	$77.62M	+23.1%
Jun 2012	$63.04M	-28.8%
Mar 2012	$88.53M	+25.8%
Dec 2011	$70.39M	+3.8%
Sep 2011	$67.84M	+9.8%
Jun 2011	$61.81M	-14.8%
Mar 2011	$72.54M	+47.3%
Dec 2010	$49.24M	-25.5%
Sep 2010	$66.13M	+233.3%
Jun 2010	-$49.62M	-170.2%
Mar 2010	$70.71M	-3.7%
Dec 2009	$73.46M	+15.0%
Sep 2009	$63.90M	+13.5%
Jun 2009	$56.28M	-11.1%
Mar 2009	$63.34M	+0.6%
Dec 2008	$62.97M	+2.6%
Sep 2008	$61.38M	+22.6%
Jun 2008	$50.07M	-28.2%

Month	Value	Change
Mar 2008	$69.77M	+38.3%
Dec 2007	$50.43M	+17.1%
Sep 2007	$43.05M	+11.7%
Jun 2007	$38.54M	-44.1%
Mar 2007	$68.98M	+33.6%
Dec 2006	$51.63M	+21.5%
Sep 2006	$42.49M	+2.5%
Jun 2006	$41.45M	-30.6%
Mar 2006	$59.72M	+13.3%
Dec 2005	$52.73M	+26.8%
Sep 2005	$41.59M	+1.1%
Jun 2005	$41.14M	-31.3%
Mar 2005	$59.90M	+12.8%
Dec 2004	$53.08M	+22.1%
Sep 2004	$43.49M	+9.5%
Jun 2004	$39.72M	-29.3%
Mar 2004	$56.18M	+11.4%
Dec 2003	$50.41M	+13.2%
Sep 2003	$44.55M	+17.5%
Jun 2003	$37.91M	-29.7%
Mar 2003	$53.93M	+19.8%
Dec 2002	$45.02M	+8.5%
Sep 2002	$41.50M	+30.3%
Jun 2002	$31.84M	-25.2%
Mar 2002	$42.58M	+21.2%
Dec 2001	$35.14M	+22.9%
Sep 2001	$28.58M	+29.9%
Jun 2001	$22.00M	-37.8%
Mar 2001	$35.40M	+7.0%
Dec 2000	$33.08M	+21.9%
Sep 2000	$27.13M	+63.2%
Jun 2000	$16.62M	+15.6%
Mar 2000	$14.37M	-52.6%
Dec 1999	$30.30M	-17.9%
Sep 1999	$36.90M	+31.6%
Jun 1999	$28.03M	-41.2%
Mar 1999	$47.69M	-1.1%
Dec 1998	$48.25M	+18.2%
Sep 1998	$40.82M	+24.1%
Jun 1998	$32.90M	-23.6%
Mar 1998	$43.03M	+12.1%
Dec 1997	$38.39M	+23.4%
Sep 1997	$31.11M	+27.9%
Jun 1997	$24.33M	-22.5%
Mar 1997	$31.40M	+22.7%
Dec 1996	$25.60M	+9.9%
Sep 1996	$23.30M	+13.1%
Jun 1996	$20.60M	-72.2%
Mar 1996	$74.20M	+1,116.4%
Dec 1995	$6.10M	+22.0%
Sep 1995	$5.00M	+19.0%
Jun 1995	$4.20M	-94.4%
Mar 1995	$74.40M	+1,857.9%
Dec 1994	$3.80M	+15.2%
Sep 1994	$3.30M	+17.9%
Jun 1994	$2.80M	-6.7%
Mar 1994	$3.00M	+30.4%
Dec 1993	$2.30M	+21.1%
Sep 1993	$1.90M	+18.8%
Jun 1993	$1.60M	+23.1%
Mar 1993	$1.30M	+62.5%
Dec 1992	$800.00K	+100.0%
Sep 1992	$400.00K	+33.3%
Jun 1992	$300.00K	+103.7%
Mar 1992	-$8.20M	-341.2%
Dec 1991	$3.40M	+36.0%
Sep 1991	$2.50M	+8.7%
Jun 1991	$2.30M	+135.9%
Mar 1991	-$6.40M	-356.0%
Dec 1990	$2.50M	+4.2%
Sep 1990	$2.40M	+50.0%
Jun 1990	$1.60M	-

FAQ

What is the current quarterly EBITDA of STE?: As of today, STE quarterly EBITDA is $477.30M
What is STE quarterly EBITDA most recent change?: STE quarterly EBITDA was up +19.65% on March 31, 2026
What is 1-year change in STE quarterly EBITDA?: STE quarterly EBITDA is up +14.62% year-over-year
How far is STE quarterly EBITDA from its all-time high?: STE quarterly EBITDA is currently at its all-time high
How does STE quarterly EBITDA rank versus sector peers?: STE quarterly EBITDA is higher than 94.72% of companies in Healthcare sector
When is STE next earnings release?: The next earnings release for STE is on November 4, 2026

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$1.63B$60.86M+3.87%

March 31, 2026

Summary

Current Value: As of today, STE TTM EBITDA is $1.63B, up +3.87% on March 31, 2026
Historical Performance: STE TTM EBITDA is up +9.74% year-over-year, up +21.98% over the past 3 years
All-Time High Comparison: STE TTM EBITDA is currently at its all-time high
3-Year Low Comparison: STE TTM EBITDA is +19.57% above its 3-year low of $1.37B reached on an earlier date
Sector Comparison: STE TTM EBITDA is higher than 94.72% of companies in Healthcare sector

Performance

STE Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Mar 31, 26	$1.63B	+3.9%	+9.7%	+22.0%	+100.0%
Annual EBITDA	Mar 31, 26	$1.63B	–	+11.7%	+19.8%	+97.5%
Quarterly EBITDA	Mar 31, 26	$477.30M	+19.6%	+14.6%	+26.1%	+117.0%
Price	Aug 7, 26	$237.47	+11.1%	+0.5%	+5.0%	+9.8%
PE Ratio	Aug 7, 26	29.93	+11.1%	-16.4%	-84.0%	-53.6%
TTM Revenue	Mar 31, 26	$5.94B	+1.9%	+8.7%	+22.3%	+91.0%
TTM EPS	Mar 31, 26	$7.93	+9.8%	+26.7%	+643.2%	+70.9%
	Mar 31, 26	$1.11B	+2.1%	+9.6%	+41.1%	+85.7%
TTM Net Income	Mar 31, 26	$785.30M	+10.3%	+28.4%	+677.2%	+97.2%

TTM EBITDA Highs

STE TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.63B	Mar 31, 26	at high
3Y	$1.63B	Mar 31, 26	at high
5Y	$1.63B	Mar 31, 26	at high
All	$1.63B	Mar 31, 26	at high

TTM EBITDA Lows

STE TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$1.50B	N/A	+8.9%
3Y	$1.37B	N/A	+19.6%
5Y	$879.20M	N/A	+85.8%
All	-$6.70M	Dec 31, 92	>+9999.0%

TTM EBITDA History

Month	Value	Change
Mar 2026	$1.63B	+3.9%
Dec 2025	$1.57B	+1.4%
Sep 2025	$1.55B	+3.3%
Jun 2025	$1.50B	+0.8%
Mar 2025	$1.49B	+2.6%
Dec 2024	$1.45B	+0.2%
Sep 2024	$1.45B	-1.3%
Jun 2024	$1.47B	+1.3%
Mar 2024	$1.45B	+0.1%
Dec 2023	$1.45B	+3.0%
Sep 2023	$1.40B	+2.8%
Jun 2023	$1.37B	+2.0%
Mar 2023	$1.34B	+1.5%
Dec 2022	$1.32B	+0.2%
Sep 2022	$1.32B	+5.6%
Jun 2022	$1.25B	+6.1%
Mar 2022	$1.18B	+13.4%
Dec 2021	$1.04B	+11.5%
Sep 2021	$929.67M	+5.7%
Jun 2021	$879.20M	+7.7%
Mar 2021	$816.53M	+0.9%
Dec 2020	$809.10M	+3.4%
Sep 2020	$782.48M	+3.0%
Jun 2020	$759.45M	+1.5%
Mar 2020	$748.44M	+3.7%
Dec 2019	$721.50M	+1.1%
Sep 2019	$713.80M	+3.2%
Jun 2019	$691.45M	+3.1%
Mar 2019	$670.43M	+3.5%
Dec 2018	$647.67M	+7.5%
Sep 2018	$602.26M	+1.2%
Jun 2018	$594.97M	+1.4%
Mar 2018	$586.66M	+13.4%
Dec 2017	$517.21M	-2.1%
Sep 2017	$528.14M	+1.4%
Jun 2017	$520.62M	+0.1%
Mar 2017	$519.88M	-10.2%
Dec 2016	$578.86M	+4.9%
Sep 2016	$551.58M	+14.6%
Jun 2016	$481.24M	+13.8%
Mar 2016	$422.85M	+17.3%
Dec 2015	$360.60M	+13.5%
Sep 2015	$317.81M	-3.7%
Jun 2015	$330.18M	+2.0%
Mar 2015	$323.56M	-3.2%
Dec 2014	$334.32M	+1.8%
Sep 2014	$328.40M	+4.6%
Jun 2014	$313.85M	+2.7%
Mar 2014	$305.55M	+5.0%
Dec 2013	$290.87M	-3.5%
Sep 2013	$301.51M	-3.1%
Jun 2013	$311.19M	-0.9%
Mar 2013	$314.04M	-0.8%
Dec 2012	$316.44M	+5.6%
Sep 2012	$299.58M	+3.4%
Jun 2012	$289.80M	+0.4%
Mar 2012	$288.56M	+5.9%
Dec 2011	$272.57M	+8.4%
Sep 2011	$251.42M	+0.7%
Jun 2011	$249.71M	+80.6%
Mar 2011	$138.28M	+1.3%
Dec 2010	$136.45M	-15.1%
Sep 2010	$160.68M	+1.4%
Jun 2010	$158.45M	-40.1%
Mar 2010	$264.35M	+2.9%
Dec 2009	$256.99M	+4.3%
Sep 2009	$246.50M	+1.0%
Jun 2009	$243.98M	+2.6%
Mar 2009	$237.77M	-2.6%
Dec 2008	$244.20M	+5.4%
Sep 2008	$231.65M	+8.6%
Jun 2008	$213.32M	+5.7%

Month	Value	Change
Mar 2008	$201.78M	+0.4%
Dec 2007	$201.00M	-0.6%
Sep 2007	$202.20M	+0.3%
Jun 2007	$201.63M	-1.4%
Mar 2007	$204.54M	+4.7%
Dec 2006	$195.28M	-0.6%
Sep 2006	$196.39M	+0.5%
Jun 2006	$195.49M	+0.2%
Mar 2006	$195.18M	-0.1%
Dec 2005	$195.36M	-0.2%
Sep 2005	$195.71M	-1.0%
Jun 2005	$197.61M	+0.7%
Mar 2005	$196.19M	+1.9%
Dec 2004	$192.46M	+1.4%
Sep 2004	$189.79M	-0.6%
Jun 2004	$190.85M	+1.0%
Mar 2004	$189.04M	+1.2%
Dec 2003	$186.79M	+3.0%
Sep 2003	$181.39M	+1.7%
Jun 2003	$178.35M	+3.5%
Mar 2003	$172.28M	+7.0%
Dec 2002	$160.94M	+6.5%
Sep 2002	$151.06M	+9.4%
Jun 2002	$138.14M	+7.7%
Mar 2002	$128.30M	+5.9%
Dec 2001	$121.12M	+1.7%
Sep 2001	$119.06M	+1.2%
Jun 2001	$117.61M	+4.8%
Mar 2001	$112.22M	+23.1%
Dec 2000	$91.19M	+3.1%
Sep 2000	$88.41M	-10.0%
Jun 2000	$98.19M	-10.4%
Mar 2000	$109.60M	-23.3%
Dec 1999	$142.92M	-11.2%
Sep 1999	$160.87M	-2.4%
Jun 1999	$164.79M	-2.9%
Mar 1999	$169.66M	+2.8%
Dec 1998	$165.00M	+6.4%
Sep 1998	$155.14M	+6.7%
Jun 1998	$145.43M	+6.3%
Mar 1998	$136.86M	+9.3%
Dec 1997	$125.23M	+11.4%
Sep 1997	$112.44M	+7.5%
Jun 1997	$104.63M	+3.7%
Mar 1997	$100.90M	-29.8%
Dec 1996	$143.70M	+15.7%
Sep 1996	$124.20M	+17.3%
Jun 1996	$105.90M	+18.3%
Mar 1996	$89.50M	-0.2%
Dec 1995	$89.70M	+2.6%
Sep 1995	$87.40M	+2.0%
Jun 1995	$85.70M	+1.7%
Mar 1995	$84.30M	+553.5%
Dec 1994	$12.90M	+13.2%
Sep 1994	$11.40M	+14.0%
Jun 1994	$10.00M	+13.6%
Mar 1994	$8.80M	+23.9%
Dec 1993	$7.10M	+26.8%
Sep 1993	$5.60M	+36.6%
Jun 1993	$4.10M	+46.4%
Mar 1993	$2.80M	+141.8%
Dec 1992	-$6.70M	-63.4%
Sep 1992	-$4.10M	-105.0%
Jun 1992	-$2.00M	>-9,900.0%
Mar 1992	$0.00	-100.0%
Dec 1991	$1.80M	+100.0%
Sep 1991	$900.00K	+12.5%
Jun 1991	$800.00K	+700.0%
Mar 1991	$100.00K	-98.5%
Dec 1990	$6.50M	+62.5%
Sep 1990	$4.00M	+150.0%
Jun 1990	$1.60M	-

FAQ

What is the current TTM EBITDA of STE?: As of today, STE TTM EBITDA is $1.63B
What is STE TTM EBITDA most recent change?: STE TTM EBITDA was up +3.87% on March 31, 2026
What is 1-year change in STE TTM EBITDA?: STE TTM EBITDA is up +9.74% year-over-year
How far is STE TTM EBITDA from its all-time high?: STE TTM EBITDA is currently at its all-time high
How does STE TTM EBITDA rank versus sector peers?: STE TTM EBITDA is higher than 94.72% of companies in Healthcare sector
When is STE next earnings release?: The next earnings release for STE is on November 4, 2026

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

STE Official Website www.steris.com
STE Profile on Yahoo Finance finance.yahoo.com/quote/STE
STE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ste